Sign up
Pharma Capital

Canopy Growth Corporation gets green light for Ontario grow operation

The new Health Canada licence allows Tweed Farms to produce 1,200 kilograms of dried marijuana.
It comes as Tweed has expanded its operation to a 375,000 sq ft facility in Ontario.

Canopy Growth Corporation (CVE:CGC) told investors that is wholly owned subsidiary Tweed Farms Inc has been given a seal of approval from Health Canada for its marijuana at its facilities in Niagara-on-the-Lake, Ontario.

The new Health Canada licence allows Tweed Farms to produce 1,200 kilograms of dried marijuana.

The licence marks the completion of a major infrastructure expansion which, according to Tweed Farms, has seen it develop a vertically integrated cannabis campus.

At a 375,000 square feet facility it is now capable of growing, trimming, curing and storing Tweed Farm’s product. Canopy Growth said Tweed Farms would now seek a final sales licence, as soon as the first cannabis crop has been harvested and tested for sale.

Bruce Linton, chief executive of Canopy Growth, said: "This infrastructure completion and Health Canada approval milestone is a testament to the team at Tweed Farms who continue to execute our capacity-building as planned."

He added: “We acquired the greenhouse twenty two months ago to position ourselves as a large scale, low-cost producer capable of supplying a sizeable percentage of the market.

"We now have three distinct facilities licensed to produce a significant amount of finished goods, offering a growing number of patients a reliable, diverse and secure supply of cannabis and related oils products."


Register here to be notified of future Company articles
View full profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.